Correlation Between Deciphera Pharmaceuticals and Dr Reddys
Can any of the company-specific risk be diversified away by investing in both Deciphera Pharmaceuticals and Dr Reddys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Deciphera Pharmaceuticals and Dr Reddys into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Deciphera Pharmaceuticals LLC and Dr Reddys Laboratories, you can compare the effects of market volatilities on Deciphera Pharmaceuticals and Dr Reddys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Deciphera Pharmaceuticals with a short position of Dr Reddys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Deciphera Pharmaceuticals and Dr Reddys.
Diversification Opportunities for Deciphera Pharmaceuticals and Dr Reddys
0.15 | Correlation Coefficient |
Average diversification
The 3 months correlation between Deciphera and RDY is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Deciphera Pharmaceuticals LLC and Dr Reddys Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dr Reddys Laboratories and Deciphera Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Deciphera Pharmaceuticals LLC are associated (or correlated) with Dr Reddys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dr Reddys Laboratories has no effect on the direction of Deciphera Pharmaceuticals i.e., Deciphera Pharmaceuticals and Dr Reddys go up and down completely randomly.
Pair Corralation between Deciphera Pharmaceuticals and Dr Reddys
Given the investment horizon of 90 days Deciphera Pharmaceuticals LLC is expected to generate 9.53 times more return on investment than Dr Reddys. However, Deciphera Pharmaceuticals is 9.53 times more volatile than Dr Reddys Laboratories. It trades about 0.2 of its potential returns per unit of risk. Dr Reddys Laboratories is currently generating about -0.08 per unit of risk. If you would invest 1,501 in Deciphera Pharmaceuticals LLC on February 8, 2024 and sell it today you would earn a total of 1,037 from holding Deciphera Pharmaceuticals LLC or generate 69.09% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Deciphera Pharmaceuticals LLC vs. Dr Reddys Laboratories
Performance |
Timeline |
Deciphera Pharmaceuticals |
Dr Reddys Laboratories |
Deciphera Pharmaceuticals and Dr Reddys Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Deciphera Pharmaceuticals and Dr Reddys
The main advantage of trading using opposite Deciphera Pharmaceuticals and Dr Reddys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Deciphera Pharmaceuticals position performs unexpectedly, Dr Reddys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dr Reddys will offset losses from the drop in Dr Reddys' long position.Deciphera Pharmaceuticals vs. Amphastar P | Deciphera Pharmaceuticals vs. Assertio Therapeutics | Deciphera Pharmaceuticals vs. Alkermes Plc | Deciphera Pharmaceuticals vs. Collegium Pharmaceutical |
Dr Reddys vs. Amphastar P | Dr Reddys vs. Assertio Therapeutics | Dr Reddys vs. Alkermes Plc | Dr Reddys vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |